ACM

Aquilo Capital Management Portfolio holdings

AUM $37.1M
This Quarter Return
+17.86%
1 Year Return
-36.49%
3 Year Return
+1.32%
5 Year Return
+39.69%
10 Year Return
AUM
$133M
AUM Growth
+$133M
Cap. Flow
-$33.2M
Cap. Flow %
-24.85%
Top 10 Hldgs %
100%
Holding
11
New
1
Increased
2
Reduced
5
Closed

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change %
Capital Flow
ARWR icon
1
Arrowhead Research
ARWR
$3.05B
$26M 19.47%
908,474
RGNX icon
2
Regenxbio
RGNX
$451M
$19.1M 14.31%
906,248
+103,824
+13% +$2.19M
BPMC
3
DELISTED
Blueprint Medicines
BPMC
$17.3M 12.95%
182,151
-72,676
-29% -$6.89M
ARVN icon
4
Arvinas
ARVN
$568M
$16.8M 12.55%
405,766
-83,387
-17% -$3.44M
KYMR icon
5
Kymera Therapeutics
KYMR
$2.95B
$15.6M 11.71%
388,743
-492,594
-56% -$19.8M
SLN
6
Silence Therapeutics
SLN
$227M
$12.4M 9.3%
574,214
-469,070
-45% -$10.1M
MRUS icon
7
Merus
MRUS
$4.98B
$11.5M 8.61%
255,109
-100,000
-28% -$4.5M
STRO icon
8
Sutro Biopharma
STRO
$72.7M
$6.58M 4.94%
1,165,466
+744,817
+177% +$4.21M
DTIL icon
9
Precision BioSciences
DTIL
$57.8M
$5.23M 3.92%
+385,440
New +$5.23M
RPTX icon
10
Repare Therapeutics
RPTX
$71.7M
$2.98M 2.24%
633,271
XBI icon
11
SPDR S&P Biotech ETF
XBI
$5.07B
0